Clinical Trials Logo

Old Age clinical trials

View clinical trials related to Old Age.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06296719 Not yet recruiting - Family Members Clinical Trials

The Chit-Chat Educational Intervention to Promote Advance Care Planning in the Community

Start date: April 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to estimate the effect size of the Chit-Chat intervention on ACP engagement among family members of older adults with multi-morbidity.

NCT ID: NCT05963399 Not yet recruiting - Old Age Clinical Trials

An Integrated Care Platform Based on the Monitoring of Older Individual Intrinsic Capacity for Inclusive Health (CAREUP)

CAREUP
Start date: April 30, 2024
Phase: N/A
Study type: Interventional

The objective of this study is to assess the usability and acceptance of the CAREUP solution in improving the quality of life at home of the older adults. The CAREUP solution is a platform that collects data from different tools such as tablets, smartwatches, ambient sensors, iHealth weight scale, and Digital Hand Dynamometer. .

NCT ID: NCT05246007 Not yet recruiting - Dexmedetomidine Clinical Trials

Nocturnal Low-dose Dexmedetomidine Infusion and Perioperative Sleep Quality

Start date: May 2022
Phase: N/A
Study type: Interventional

Sleep disturbances are prevalent in older patients with osteoarthrosis or fracture scheduled for knee or hip replacement surgery. The occurrence of sleep disturbances is associated with worse outcomes including increased risk of delirium and cardiac events, and worsened functional recovery. Dexmedetomidine is a highly selective α2-adrenergic agonist with sedative, anxiolytic, and analgesic properties. It exerts sedative effects via activating the endogenous sleep pathways and produces a state like non-rapid eye movement sleep, which is different from opioid- and benzodiazepine-induced sedation. Night-time infusion of low-dose dexmedetomidine may improve sleep quality. However, evidence in this aspect is limited.

NCT ID: NCT04953312 Not yet recruiting - Clinical trials for Myelodysplastic Syndromes

Calprotectin, a Biomarker of COVID-19 Severity (CALPRO)

CALPRO
Start date: January 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to provide new insights into the pathophysiology of emergency hematopoiesis detected in severe COVID-19 patients. The investigators aim to explore the ability of calprotectin to induce an immunosuppressive myeloid program at the hematopoietic stem and progenitor cell (HSPC) level, and to identify the receptor(s) involved in this effect. Since patients with a hematological malignancy demonstrate a very high propensity to develop a severe COVID-19, the investigators will explore how HSPCs collected from patients with a myeloid malignancy respond to calprotectin.

NCT ID: NCT03484715 Not yet recruiting - Old Age Clinical Trials

Feasibility of a Physical Activity Programme for Older Adults in Nursing Homes

Start date: May 1, 2018
Phase: N/A
Study type: Interventional

Older people living in nursing homes spend the majority of their time inactive. The current study has designed a physical activity intervention for older people living in nursing homes whereby the participants will incorporate more physical activity throughout their daily activities. Each participant's physical activity programme will be tailored to their physical abilities and to a pre-defined goal. The aim of this pilot feasibility study is to explore the feasibility and acceptability of this physical activity programme and to examine the preliminary effects of this on physical mobility and health-related quality of life, when compared to a usual care control group.